Ken Fisher Fisher Asset Management
Ken Fisher is the founder and executive chairman of Fisher Investments, a global money management firm overseeing billions of dollars in assets. He gained early recognition for pioneering the use of the price-to-sales ratio in stock analysis and wrote the long-running “Portfolio Strategy” column in Forbes. Over the years, Fisher has authored numerous books on investing and wealth management, many of which have become bestsellers.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$907M |
| 2 |
Apple
AAPL
|
+$260M |
| 3 |
Microsoft
MSFT
|
+$223M |
| 4 |
Amazon
AMZN
|
+$173M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$160M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$471M |
| 2 |
NVO
Novo Nordisk
NVO
|
+$177M |
| 3 |
AZPN
ASPEN TECHNOLOGY INC
AZPN
|
+$160M |
| 4 |
Petrobras
PBR
|
+$153M |
| 5 |
Adobe
ADBE
|
+$146M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.79% |
| 2 | Healthcare | 12.41% |
| 3 | Financials | 9.98% |
| 4 | Consumer Discretionary | 9.11% |
| 5 | Communication Services | 6.49% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
476
Anika Therapeutics
ANIK
$287M
| $2.23M | ﹤0.01% |
99,908
| – | – |
|
477
IQVIA
IQV
$39.3B
| $2.22M | ﹤0.01% |
10,215
-620
| -6% | -$135K |
|
478
Republic Services
RSG
$66B
| $2.21M | ﹤0.01% |
16,909
-61,743
| -79% | -$8.11M |
|
479
Central Pacific Financial
CPF
$1B
| $2.17M | ﹤0.01% |
101,382
+26,299
| +35% | +$638K |
|
480
Valero Energy
VLO
$85.9B
| $2.16M | ﹤0.01% |
20,345
+3,418
| +20% | +$405K |
|
481
Sarepta Therapeutics
SRPT
$1.77B
| $2.16M | ﹤0.01% |
28,806
-2,696
| -9% | -$198K |
|
482
Designer Brands
DBI
$333M
| $2.13M | ﹤0.01% |
163,075
+47,676
| +41% | +$687K |
|
483
State Street SPDR S&P 500 ETF Trust
SPY
$823B
| $2.09M | ﹤0.01% |
5,543
-608
| -10% | -$249K |
|
484
Baidu
BIDU
$37.2B
| $2.09M | ﹤0.01% |
14,024
+1,573
| +13% | +$208K |
|
485
Vipshop
VIPS
$7.53B
| $2.08M | ﹤0.01% |
210,361
+15,844
| +8% | +$140K |
|
486
Donnelley Financial Solutions
DFIN
$1.16B
| $2.05M | ﹤0.01% |
+70,044
| New | +$2.08M |
|
487
lululemon athletica
LULU
$14.6B
| $2.05M | ﹤0.01% |
7,527
+864
| +13% | +$277K |
|
|
CPRX
488
DELISTED
Catalyst Pharmaceutical
CPRX
| $2.04M | ﹤0.01% |
290,897
+30,429
| +12% | +$223K |
|
489
Dropbox
DBX
$8.12B
| $2M | ﹤0.01% |
+95,031
| New | +$2.06M |
|
490
Nasdaq
NDAQ
$52.9B
| $1.98M | ﹤0.01% |
38,856
-20,073
| -34% | -$1.06M |
|
491
Altria Group
MO
$114B
| $1.95M | ﹤0.01% |
46,688
+3,673
| +9% | +$190K |
|
492
Genpact
G
$5.81B
| $1.89M | ﹤0.01% |
44,633
-467
| -1% | -$19.8K |
|
493
MakeMyTrip
MMYT
$5.64B
| $1.87M | ﹤0.01% |
72,873
| – | – |
|
494
Progressive
PGR
$125B
| $1.86M | ﹤0.01% |
16,011
+128
| +0.8% | +$14.5K |
|
495
Expeditors International
EXPD
$23.2B
| $1.86M | ﹤0.01% |
19,075
-299
| -2% | -$30.6K |
|
496
Korn Ferry
KFY
$4.28B
| $1.85M | ﹤0.01% |
31,871
-41
| -0.1% | -$2.49K |
|
497
Amdocs
DOX
$6.22B
| $1.82M | ﹤0.01% |
21,900
-292
| -1% | -$24.1K |
|
498
Stewart Information Services
STC
$2.08B
| $1.82M | ﹤0.01% |
36,632
| – | – |
|
499
AT&T
T
$163B
| $1.82M | ﹤0.01% |
86,634
-30,609
| -26% | -$610K |
|
500
Banner Corp
BANR
$2.4B
| $1.8M | ﹤0.01% |
31,952
-1,005
| -3% | -$56.1K |
|
Similar funds
Ken Fisher's Q2 2022 Portfolio in Review
As of Q2 2022, Ken Fisher held 1,196 positions worth $141B, down 17% from $169B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Ken Fisher's Q2 2022 filing shows 110 new, 483 increased, 318 reduced and 131 closed positions. Its largest new stake was Woodside Energy: 6,156,348 shares worth $133M. The largest sale was Eli Lilly, an estimated $471M.
By sector, the portfolio is most concentrated in Technology at 28% of assets, down from 29% a quarter earlier, followed by Healthcare and Financials.
- Ken Fisher's largest Q2 2022 buy was Woodside Energy: 6,156,348 shares worth $133M.
- Ken Fisher added most to Johnson & Johnson in Q2 2022, an estimated $907M increase.
- Ken Fisher's biggest Q2 2022 reduction was Eli Lilly, cutting an estimated $471M.
- Ken Fisher fully exited ASPEN TECHNOLOGY INC in Q2 2022, selling an estimated $160M.
- Ken Fisher's ten largest holdings make up 30% of its $141B portfolio in Q2 2022.
- Ken Fisher opened 110 new positions and closed 131 in Q2 2022.
- Ken Fisher's portfolio value fell 17% quarter-over-quarter to $141B.
Based on Fisher Asset Management's 13F filing for Q2 2022, filed 9 Aug 2022.